Neutrophilic Cell‐Free Exudate Induces Antinociception Mediate by the Protein S100A9
Authors:
Open Access
- 1 January 2006
- journal article
- research article
- Published by Wiley in Mediators of Inflammation
- Vol. 2006 (1) , 36765
Abstract
Calcium-binding protein S100A9 (MRP-14) induces antinociceptive effect in an experimental model of painful sensibility and participates of antinociception observed during neutrophilic peritonitis induced by glycogen or carrageenan in mice. In this study, the direct antinociceptive role of the protein S100A9 in neutrophilic cell-free exudates obtained of mice injected with glycogen was investigated. Mice were intraperitoneally injected with a glycogen solution, and after , , , and hours, either the pattern of cell migration of the peritoneal exudate or the nociceptive response of animals was evaluated. The glycogen-induced neutrophilic peritonitis evoked antinociception and hours after inoculation of the irritant. Peritoneal cell-free exudates, collected in different times after the irritant injection, were transferred to naive animals which were submitted to the nociceptive test. The transference of exudates also induced antinociceptive effect, and neutralization of S100A9 activity by anti-S100A9 monoclonal antibody totally reverted this response. This effect was not observed when experiments were made or hours after glycogen injection. These results clearly indicate that S100A9 is secreted during glycogen-induced neutrophilic peritonitis, and that this protein is responsible by antinociception observed in the initial phase of inflammatory reaction. Thus, these data reinforce the hypothesis that the calcium-binding protein S100A9 participates of the endogenous control of inflammatory pain.
Keywords
Funding Information
- Fundação de Amparo à Pesquisa do Estado de São Paulo
- Fundação Butantan
This publication has 39 references indexed in Scilit:
- The C-terminus of murine S100A9 inhibits hyperalgesia and edema induced by jararhaginPeptides, 2004
- Cytokine‐mediated inflammatory hyperalgesia limited by interleukin‐4British Journal of Pharmacology, 1999
- Isolation of a YAC clone covering a cluster of nine S100 genes on human chromosome 1q21: rationale for a new nomenclature of the S100 calcium-binding protein familyGenomics, 1995
- Effects of calprotectin in avridine‐induced arthritisAPMIS, 1995
- Antimicrobial actions of calcium binding leucocyte L1 protein, calprotectinThe Lancet, 1990
- Differential expression of the calcium-binding proteins MRP8 and MRP14 in granulomatous conditions: an immunohistochemical studyClinical and Experimental Immunology, 1990
- The S100 protein familyTrends in Biochemical Sciences, 1988
- The Leucocyte L1 Protein: Identity with the Cystic Fibrosis Antigen and the Calcium‐Binding MRP‐8 and MRP‐14 Macrophage ComponentsScandinavian Journal of Immunology, 1988
- Ethical guidelines for investigations of experimental pain in conscious animalsPain, 1983
- Multiple Range and Multiple F TestsBiometrics, 1955